Eintrag weiter verarbeiten
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia
Gespeichert in:
| Zeitschriftentitel: | Blood |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , |
| In: | Blood, 119, 2012, 22, S. 5229-5238 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Society of Hematology
|
| Schlagwörter: |
| author_facet |
Aimiuwu, Josephine Wang, Hongyan Chen, Ping Xie, Zhiliang Wang, Jiang Liu, Shujun Klisovic, Rebecca Mims, Alice Blum, William Marcucci, Guido Chan, Kenneth K. Aimiuwu, Josephine Wang, Hongyan Chen, Ping Xie, Zhiliang Wang, Jiang Liu, Shujun Klisovic, Rebecca Mims, Alice Blum, William Marcucci, Guido Chan, Kenneth K. |
|---|---|
| author |
Aimiuwu, Josephine Wang, Hongyan Chen, Ping Xie, Zhiliang Wang, Jiang Liu, Shujun Klisovic, Rebecca Mims, Alice Blum, William Marcucci, Guido Chan, Kenneth K. |
| spellingShingle |
Aimiuwu, Josephine Wang, Hongyan Chen, Ping Xie, Zhiliang Wang, Jiang Liu, Shujun Klisovic, Rebecca Mims, Alice Blum, William Marcucci, Guido Chan, Kenneth K. Blood RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia Cell Biology Hematology Immunology Biochemistry |
| author_sort |
aimiuwu, josephine |
| spelling |
Aimiuwu, Josephine Wang, Hongyan Chen, Ping Xie, Zhiliang Wang, Jiang Liu, Shujun Klisovic, Rebecca Mims, Alice Blum, William Marcucci, Guido Chan, Kenneth K. 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2011-11-382226 <jats:title>Abstract</jats:title> <jats:p>5-Azacytidine (5-azaC) is an azanucleoside approved for myelodysplastic syndrome. Approximately 80%-90% of 5-azaC is believed to be incorporated into RNA, which disrupts nucleic acid and protein metabolism leading to apoptosis. A smaller fraction (10%-20%) of 5-azaC inhibits DNA methylation and synthesis through conversion to decitabine triphosphate and subsequent DNA incorporation. However, its precise mechanism of action remains unclear. Ribonucleotide reductase (RR) is a highly regulated enzyme comprising 2 subunits, RRM1 and RRM2, that provides the deoxyribonucleotides required for DNA synthesis/repair. In the present study, we found for the first time that 5-azaC is a potent inhibitor of RRM2 in leukemia cell lines, in a mouse model, and in BM mononuclear cells from acute myeloid leukemia (AML) patients. 5-azaC–induced RRM2 gene expression inhibition involves its direct RNA incorporation and an attenuated RRM2 mRNA stability. Therefore, 5-azaC causes a major perturbation of deoxyribonucleotide pools. We also demonstrate herein that the initial RR-mediated 5-azaC conversion to decitabine is terminated through its own inhibition. In conclusion, we identify RRM2 as a novel molecular target of 5-azaC in AML. Our findings provide a basis for its more widespread clinical use either alone or in combination.</jats:p> RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia Blood |
| doi_str_mv |
10.1182/blood-2011-11-382226 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin Chemie und Pharmazie Biologie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDExLTExLTM4MjIyNg |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDExLTExLTM4MjIyNg |
| institution |
DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 |
| imprint |
American Society of Hematology, 2012 |
| imprint_str_mv |
American Society of Hematology, 2012 |
| issn |
0006-4971 1528-0020 |
| issn_str_mv |
0006-4971 1528-0020 |
| language |
English |
| mega_collection |
American Society of Hematology (CrossRef) |
| match_str |
aimiuwu2012rnadependentinhibitionofribonucleotidereductaseisamajorpathwayfor5azacytidineactivityinacutemyeloidleukemia |
| publishDateSort |
2012 |
| publisher |
American Society of Hematology |
| recordtype |
ai |
| record_format |
ai |
| series |
Blood |
| source_id |
49 |
| title |
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| title_unstemmed |
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| title_full |
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| title_fullStr |
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| title_full_unstemmed |
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| title_short |
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| title_sort |
rna-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| topic |
Cell Biology Hematology Immunology Biochemistry |
| url |
http://dx.doi.org/10.1182/blood-2011-11-382226 |
| publishDate |
2012 |
| physical |
5229-5238 |
| description |
<jats:title>Abstract</jats:title>
<jats:p>5-Azacytidine (5-azaC) is an azanucleoside approved for myelodysplastic syndrome. Approximately 80%-90% of 5-azaC is believed to be incorporated into RNA, which disrupts nucleic acid and protein metabolism leading to apoptosis. A smaller fraction (10%-20%) of 5-azaC inhibits DNA methylation and synthesis through conversion to decitabine triphosphate and subsequent DNA incorporation. However, its precise mechanism of action remains unclear. Ribonucleotide reductase (RR) is a highly regulated enzyme comprising 2 subunits, RRM1 and RRM2, that provides the deoxyribonucleotides required for DNA synthesis/repair. In the present study, we found for the first time that 5-azaC is a potent inhibitor of RRM2 in leukemia cell lines, in a mouse model, and in BM mononuclear cells from acute myeloid leukemia (AML) patients. 5-azaC–induced RRM2 gene expression inhibition involves its direct RNA incorporation and an attenuated RRM2 mRNA stability. Therefore, 5-azaC causes a major perturbation of deoxyribonucleotide pools. We also demonstrate herein that the initial RR-mediated 5-azaC conversion to decitabine is terminated through its own inhibition. In conclusion, we identify RRM2 as a novel molecular target of 5-azaC in AML. Our findings provide a basis for its more widespread clinical use either alone or in combination.</jats:p> |
| container_issue |
22 |
| container_start_page |
5229 |
| container_title |
Blood |
| container_volume |
119 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792347419133870088 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:54:46.035Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=RNA-dependent+inhibition+of+ribonucleotide+reductase+is+a+major+pathway+for+5-azacytidine+activity+in+acute+myeloid+leukemia&rft.date=2012-05-31&genre=article&issn=1528-0020&volume=119&issue=22&spage=5229&epage=5238&pages=5229-5238&jtitle=Blood&atitle=RNA-dependent+inhibition+of+ribonucleotide+reductase+is+a+major+pathway+for+5-azacytidine+activity+in+acute+myeloid+leukemia&aulast=Chan&aufirst=Kenneth+K.&rft_id=info%3Adoi%2F10.1182%2Fblood-2011-11-382226&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792347419133870088 |
| author | Aimiuwu, Josephine, Wang, Hongyan, Chen, Ping, Xie, Zhiliang, Wang, Jiang, Liu, Shujun, Klisovic, Rebecca, Mims, Alice, Blum, William, Marcucci, Guido, Chan, Kenneth K. |
| author_facet | Aimiuwu, Josephine, Wang, Hongyan, Chen, Ping, Xie, Zhiliang, Wang, Jiang, Liu, Shujun, Klisovic, Rebecca, Mims, Alice, Blum, William, Marcucci, Guido, Chan, Kenneth K., Aimiuwu, Josephine, Wang, Hongyan, Chen, Ping, Xie, Zhiliang, Wang, Jiang, Liu, Shujun, Klisovic, Rebecca, Mims, Alice, Blum, William, Marcucci, Guido, Chan, Kenneth K. |
| author_sort | aimiuwu, josephine |
| container_issue | 22 |
| container_start_page | 5229 |
| container_title | Blood |
| container_volume | 119 |
| description | <jats:title>Abstract</jats:title> <jats:p>5-Azacytidine (5-azaC) is an azanucleoside approved for myelodysplastic syndrome. Approximately 80%-90% of 5-azaC is believed to be incorporated into RNA, which disrupts nucleic acid and protein metabolism leading to apoptosis. A smaller fraction (10%-20%) of 5-azaC inhibits DNA methylation and synthesis through conversion to decitabine triphosphate and subsequent DNA incorporation. However, its precise mechanism of action remains unclear. Ribonucleotide reductase (RR) is a highly regulated enzyme comprising 2 subunits, RRM1 and RRM2, that provides the deoxyribonucleotides required for DNA synthesis/repair. In the present study, we found for the first time that 5-azaC is a potent inhibitor of RRM2 in leukemia cell lines, in a mouse model, and in BM mononuclear cells from acute myeloid leukemia (AML) patients. 5-azaC–induced RRM2 gene expression inhibition involves its direct RNA incorporation and an attenuated RRM2 mRNA stability. Therefore, 5-azaC causes a major perturbation of deoxyribonucleotide pools. We also demonstrate herein that the initial RR-mediated 5-azaC conversion to decitabine is terminated through its own inhibition. In conclusion, we identify RRM2 as a novel molecular target of 5-azaC in AML. Our findings provide a basis for its more widespread clinical use either alone or in combination.</jats:p> |
| doi_str_mv | 10.1182/blood-2011-11-382226 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin, Chemie und Pharmazie, Biologie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDExLTExLTM4MjIyNg |
| imprint | American Society of Hematology, 2012 |
| imprint_str_mv | American Society of Hematology, 2012 |
| institution | DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1 |
| issn | 0006-4971, 1528-0020 |
| issn_str_mv | 0006-4971, 1528-0020 |
| language | English |
| last_indexed | 2024-03-01T17:54:46.035Z |
| match_str | aimiuwu2012rnadependentinhibitionofribonucleotidereductaseisamajorpathwayfor5azacytidineactivityinacutemyeloidleukemia |
| mega_collection | American Society of Hematology (CrossRef) |
| physical | 5229-5238 |
| publishDate | 2012 |
| publishDateSort | 2012 |
| publisher | American Society of Hematology |
| record_format | ai |
| recordtype | ai |
| series | Blood |
| source_id | 49 |
| spelling | Aimiuwu, Josephine Wang, Hongyan Chen, Ping Xie, Zhiliang Wang, Jiang Liu, Shujun Klisovic, Rebecca Mims, Alice Blum, William Marcucci, Guido Chan, Kenneth K. 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2011-11-382226 <jats:title>Abstract</jats:title> <jats:p>5-Azacytidine (5-azaC) is an azanucleoside approved for myelodysplastic syndrome. Approximately 80%-90% of 5-azaC is believed to be incorporated into RNA, which disrupts nucleic acid and protein metabolism leading to apoptosis. A smaller fraction (10%-20%) of 5-azaC inhibits DNA methylation and synthesis through conversion to decitabine triphosphate and subsequent DNA incorporation. However, its precise mechanism of action remains unclear. Ribonucleotide reductase (RR) is a highly regulated enzyme comprising 2 subunits, RRM1 and RRM2, that provides the deoxyribonucleotides required for DNA synthesis/repair. In the present study, we found for the first time that 5-azaC is a potent inhibitor of RRM2 in leukemia cell lines, in a mouse model, and in BM mononuclear cells from acute myeloid leukemia (AML) patients. 5-azaC–induced RRM2 gene expression inhibition involves its direct RNA incorporation and an attenuated RRM2 mRNA stability. Therefore, 5-azaC causes a major perturbation of deoxyribonucleotide pools. We also demonstrate herein that the initial RR-mediated 5-azaC conversion to decitabine is terminated through its own inhibition. In conclusion, we identify RRM2 as a novel molecular target of 5-azaC in AML. Our findings provide a basis for its more widespread clinical use either alone or in combination.</jats:p> RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia Blood |
| spellingShingle | Aimiuwu, Josephine, Wang, Hongyan, Chen, Ping, Xie, Zhiliang, Wang, Jiang, Liu, Shujun, Klisovic, Rebecca, Mims, Alice, Blum, William, Marcucci, Guido, Chan, Kenneth K., Blood, RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia, Cell Biology, Hematology, Immunology, Biochemistry |
| title | RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| title_full | RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| title_fullStr | RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| title_full_unstemmed | RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| title_short | RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| title_sort | rna-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| title_unstemmed | RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia |
| topic | Cell Biology, Hematology, Immunology, Biochemistry |
| url | http://dx.doi.org/10.1182/blood-2011-11-382226 |